Product Information

FENOFIBRATE 160 MG TABLET is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.1129 per EA under NDC 69367025409. Its NADAC has been published 327 times since May 20, 2020.

FDA first approved this application on Dec 19, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FENOFIBRATE 160 MG TABLET

Fenofibrate
$0.1129per EA

Strength

160 mg/1

NDC

69367025409

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

FENOFIBRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA207803

FDA Approved

12/19/2017

TE Code

AB

On Market Since

4/23/2020

Price Statistics

The NADAC for FENOFIBRATE 160 MG TABLET has been published 327 times since May 20, 2020, and over the history we have for it it has declined 57.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1129 per EA
All-time high$0.3230 (Jul 15, 2020)
All-time low$0.0892 (Dec 17, 2025)
52-week high$0.1259
52-week low$0.0892
Median price$0.1504
Average price$0.1628
Largest weekly change+41.1% (Jan 17, 2024)
Weeks tracked327
Tracking sinceMay 20, 2020

Price History

1W

+0.9%

1M

+0.9%

3M

-8.9%

6M

+11.9%

1Y

-10.1%

3Y

-31.9%

5Y

-48.2%

All

-57.0%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FENOFIBRATE 160 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 160 MG TABLET, manufactured by Westminster Pharmaceuticals LLC, is $0.1129 per EA (NDC 69367025409), effective Aug 19, 2026.

How has the price of FENOFIBRATE 160 MG TABLET changed over time?

Over the history we have for it, the NADAC for FENOFIBRATE 160 MG TABLET has declined 57.0%. It has been tracked across 327 weekly CMS publications since May 20, 2020.

What are the highest and lowest recorded NADAC prices for FENOFIBRATE 160 MG TABLET?

Since May 20, 2020, the NADAC for FENOFIBRATE 160 MG TABLET has ranged from a low of $0.0892 (Dec 17, 2025) to a high of $0.3230 (Jul 15, 2020), with a median of $0.1504 per EA.

Are there cheaper alternatives to FENOFIBRATE 160 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FENOFIBRATE 160 MG TABLET, is $0.1008 per EA — about 11% below FENOFIBRATE 160 MG TABLET.

Who manufactures FENOFIBRATE 160 MG TABLET?

FENOFIBRATE 160 MG TABLET (NDC 69367025409) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.